Concepedia

Author

Jean Bauer

University Hospital of Lausanne

Also Known As

Bauer, J., J A Bauer, J BAUER, J Bauer, J. A. Bauer, J. Bauer, J.A. Bauer, James A. Bauer, Jean A Bauer, Jean Bauer

80

Publications

2.3K

Citations

24

H-Index

60

Concepts

All Affiliations

University Hospital of LausanneUniversity of LausanneOspedale San Giovanni BellinzonaUniversity Hospital of BernKantonsspital St. Gallen
JB

About

Jean Bauer is an author at University Hospital of Lausanne specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

20

1K

2

Natural Sciences

3

3

134

3

Biochemistry

3

3

154

4

Health Sciences

1

1

25

5

Allergy

1

1

15

Jean Bauer

×

32

Publications

2.2K

Citations

24

H-Index

YearCitations

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Richard Herrmann, G. Bodoky, Thomas Ruhstaller,

Journal of Clinical Oncology

2007

590

Trabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes Fails

Cristiana Sessa, Filippo de Braud, Antonella Perotti,

Journal of Clinical Oncology

2005

164

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

Diana Crivellari, Olivia Pagani, Andrea Veronesi,

Annals of Oncology

2001

150

Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial—SAKK 44/00–CECOG/PAN.1.3.001

Jürg Bernhard, Daniel Dietrich, Werner Scheithauer,

Journal of Clinical Oncology

2008

101

Regulation of eicosanoid biosynthesis in the macrophage

Keith B. Glaser, Amy Sung, Jean Bauer,

Biochemical Pharmacology

1993

99

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study

Seppo Pyrhönen, Ritva Valavaara, Hans Modig,

British Journal of Cancer

1997

98

Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex

Cristiana Sessa, Giuseppe Capri, Luca Gianni,

Annals of Oncology

2000

75

Pharmacokinetics of Pamidronate in Patients With Bone Metastases

Serge Leyvraz, U Hess, Gérard Flesch,

JNCI Journal of the National Cancer Institute

1992

68

Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration

Catia Marzolini, Fei Shen, Jean Bauer,

Cancer Chemotherapy and Pharmacology

1998

66

A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma

Monika Jermann, Rolf A. Stahel, Marc Salzberg,

Cancer Chemotherapy and Pharmacology

2005

58

Page 1